Krystal Biotech has released its third-quarter 2026 earnings call presentation, detailing results for the period. The company, traded on the NASDAQ under KRYS, is presenting its financial and operational update to investors. The materials give shareholders a look at the company’s performance and pipeline progress. Investors will be watching for revenue trends and guidance in the presentation. The release marks another milestone in the company’s quarterly reporting cycle.